
23andMe's breast cancer test may create false sense of security
7 March 2018
Genomics firm 23andMe is the first to receive approval for direct-to-consumer cancer gene tests in the US, but will recipients misunderstand the results?

7 March 2018
Genomics firm 23andMe is the first to receive approval for direct-to-consumer cancer gene tests in the US, but will recipients misunderstand the results?

7 March 2018
Using algorithms to monitor cancer evolution and apply game theory to their treatment has doubled the survival time of men with advanced prostate cancer

11 May 2017
One man’s bowel cancer has been tracked from the very start to the very end, revealing some of the surprising ways in which the disease spreads through the body